Results 181 to 190 of about 68,914 (294)

The euros and sense of stents: do we get value for money? [PDF]

, 2011
Annemans, Lieven
core   +1 more source

SIROLIMUS IN ASSOCIATION WITH MYCOPHENOLATE MOFETIL INDUCTION FOR THE PREVENTION OF ACUTE GRAFT REJECTION IN RENAL ALLOGRAFT RECIPIENTS12

, 2000
Henri Kreis, Jean‐Marc Cisterne, W. Land, Lars Wramner, Jean‐Paul Squifflet, Daniel Abramowicz, Josep M. Campistol, Jos -Maria Morales, Jos -Maria Grinyo, Georges Mourad, Fran ois-Claude Berthoux, Christina Brattstr m, Yvon Lebranchu, P Vialtel   +13 more
openalex   +1 more source

Stent-Based Delivery of Sirolimus Reduces Neointimal Formation in a Porcine Coronary Model [PDF]

, 2001
Takeshi Suzuki, Greg Kopia, S. Hayashi, Lynn Bailey, Gerard R. Llanos, Robert Wilensky, Bruce D. Klugherz, George Papandreou, Pallassana Narayan, Martin B. Leon, Alan C. Yeung, Fermin O. Tio, Philip S. Tsao, Robert Falotico, Andrew J. Carter   +14 more
openalex   +1 more source

Safety and efficacy of sirolimus combined with cyclosporine in primary membranous nephropathy: a randomized controlled trial. [PDF]

BMC Med
Wang F, Yang C, Shu Y, Lin CX, Yao Y, Li Y, Zhang YM, Wang X, Meng LQ, Cheng XY, Liu G, Zhao MH, Cui Z.   +12 more
europepmc   +1 more source

SIROLIMUS-INDUCED THROMBOCYTOPENIA AND LEUKOPENIA IN RENAL TRANSPLANT RECIPIENTS: RISK FACTORS, INCIDENCE, PROGRESSION, AND MANAGEMENT12

, 2000
Johnny C. Hong, Barry D. Kahan
openalex   +1 more source

Sustained Suppression of Neointimal Proliferation by Sirolimus-Eluting Stents [PDF]

, 2001
J. Eduardo Sousa, Marco A. Costa, Alexandre Abizaid, Benno J. Rensing, Alexandre Abizaid, Luiz Fernando Tanajura, Ken Kozuma, Glenn Van Langenhove, Amanda G. M. R. Sousa, Robert Falotico, Judith Jaeger, Jeffrey J. Popma, Patrick W. Serruys   +12 more
openalex   +1 more source

Sirolimus: A new agent for prevention of renal allograft rejection

, 2000
Eva M. Vasquez
openalex   +1 more source

Lung Transplantation Outcomes and Peritransplant Sirolimus Use in Lymphangioleiomyomatosis

Annals of Thoracic Surgery Short Reports
Background: With the introduction of sirolimus as medical therapy for lymphangioleiomyomatosis (LAM), an updated evaluation of LAM lung transplant (LT) outcomes and characterization of peritransplant sirolimus use is needed.
Emily L. Larson, BS, Reed T. Jenkins, BA, Jessica M. Ruck, MD, Laura B. Zeiser, MS, Alice L. Zhou, MS, Alfred J. Casillan, MD, PhD, Dorry L. Segev, MD, Allan B. Massie, MD, Jinny S. Ha, MD, Pali D. Shah, MD, Christian A. Merlo, MD, MPH, Errol L. Bush, MD   +11 more
doaj  

Additive Therapeutic Effects of Topical Sirolimus Following Oral Propranolol Therapy for Kaposiform Hemangioendothelioma. [PDF]

Clin Cosmet Investig Dermatol
Xiu B, Xu Z, Xu Z, Zhang B, Wei L, Ma L.
europepmc   +1 more source

Clinical use of immunosuppressants [PDF]

, 2005
Fung, JJ, Schonder, KS, Starzl, TE, Weber, RJ   +3 more
core